Grants per year
Personal profile
Research Interests
Anti-thrombotic therapy, Atrial fibrillation, Cardiac stress testing, Cardiovascular critical care, Coronary heart disease, Ischemic heart disease, Nuclear cardiology
Certifications and Licenses
| Internal Medicine | |
| Cardiovascular Disease |
Training Experience
| 1982 | Residency, Mt. Sinai Hospital |
| 1985 | Fellowship, Johns Hopkins Hospital |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Harvard University
… → 1979
Research interests keywords
- Cardiology
- Cardiovascular Diseases
- Cardiovascular Imaging
- Lipid Disorders
Fingerprint
Dive into the research topics where Dan J Fintel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 22 Finished
-
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
Kho, A. N. (PD/PI) & Fintel, D. J. (Co-PD/PI)
Chicago Community Trust, Patient-Centered Outcomes Research Institute
7/1/16 → 9/14/18
Project: Research project
-
Protocol CACZ885M2301: A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-Myocardial Infarction Patients with Elevated hsCRP
Fintel, D. J. (PD/PI)
Novartis Pharmaceuticals Corporation
10/11/11 → 10/31/18
Project: Research project
-
ALERTS (AngeLmed for Early Recognition and Treatment of STEMI) Study
Fintel, D. J. (PD/PI)
12/8/10 → 12/8/19
Project: Research project
-
(TERMINATED)PROT# CV185068: APPRAISE-2 Apixaban for Prevention of Acute Ischemic Safety Events-2 A Phase 3 Randomized Evaluation of the Safety and Efficacy of Apixaban in Patients with a Recent Acute Coronary Syndrome: Pharmacogenetics Blood Sample
Fintel, D. J. (PD/PI)
PPD Development, Bristol-Myers Squibb Company
9/18/09 → 9/17/12
Project: Research project
-
Prot# 34976: A 12-Month Follow-Up Study to Protocol 24779 (A Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells
Davidson, C. J. (PD/PI), Benzuly, K. H. (Co-PD/PI), Fintel, D. J. (Co-PD/PI), Flaherty, J. D. (Co-PD/PI) & Meyers, S. N. (Co-PD/PI)
United BioSource LLC, Baxter Healthcare Corporation
11/26/08 → 11/25/11
Project: Research project
-
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
the RADIANCE Investigators and Collaborators, May 10 2023, In: JAMA cardiology. 8, 5, JOI230007.Research output: Contribution to journal › Article › peer-review
Open Access46 Scopus citations -
Comparative effectiveness of aspirin dosing in cardiovascular disease
Jones, W. S., Mulder, H., Wruck, L. M., Pencina, M. J., Kripalani, S., Muñoz, D., Crenshaw, D. L., Effron, M. B., Re, R. N., Gupta, K., David Anderson, R., Pepine, C. J., Handberg, E. M., Manning, B. R., Jain, S. K., Girotra, S., Riley, D., DeWalt, D. A., Whittle, J. & Goldberg, Y. H. & 51 others, , May 27 2021, In: New England Journal of Medicine. 384, 21, p. 1981-1990 10 p.Research output: Contribution to journal › Article › peer-review
Open Access178 Scopus citations -
Comparison of Metoprolol Versus Carvedilol After Acute Myocardial Infarction
Outcomes of Beta-blocker Therapy After myocardial INfarction (OBTAIN) Investigators, May 15 2021, In: American Journal of Cardiology. 147, p. 1-7 7 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial
Marquis-Gravel, G., Roe, M. T., Robertson, H. R., Harrington, R. A., Pencina, M. J., Berdan, L. G., Hammill, B. G., Faulkner, M., Munõz, D., Fonarow, G. C., Nallamothu, B. K., Fintel, D. J., Ford, D. E., Zhou, L., Daugherty, S. E., Nauman, E., Kraschnewski, J., Ahmad, F. S., Benziger, C. P. & Haynes, K. & 24 others, , May 2020, In: JAMA cardiology. 5, 5, p. 598-607 10 p.Research output: Contribution to journal › Article › peer-review
66 Scopus citations -
Utility of the ACE Inhibitor Captopril in Mitigating Radiation-Associated Pulmonary Toxicity in Lung Cancer
Small, W., James, J. L., Moore, T. D., Fintel, D. J., Lutz, S. T., Movsas, B., Suntharalingam, M., Garces, Y. I., Ivker, R., Moulder, J., Pugh, S. & Berk, L. B., 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 4, p. 396-401 6 p.Research output: Contribution to journal › Article › peer-review
26 Scopus citations